放射学与非放射学中轴型脊柱关节炎三项试验结局指标的重测信度
本研究利用COAST-V、COAST-X和RAPID-axSpA三项试验的筛查与基线数据,评估ASAS-OMERACT中轴型脊柱关节炎核心集中候选仪器的重测信度,两次访视间隔不超过28天。结果显示总体信度良好,放射学与非放射学中轴型脊柱关节炎亚组的信度和最小可检测变化相似,复合指标的信度高于单项指标。
要点
- ASDAS信度良好(ICC 0.79,SDC 0.6),BASFI信度良好(ICC 0.87,SDC 1.1)。
- BASDAI、患者总体评估、背痛、晨僵、疲劳等单项指标信度为中等。
- 放射学与非放射学中轴型脊柱关节炎亚组的信度和SDC相似。
核心结论
- 总体信度良好,放射学与非放射学中轴型脊柱关节炎患者的信度水平相当,尽管多数仪器是为放射学中轴型脊柱关节炎开发的。
- 复合指标在评估中轴型脊柱关节炎患者疾病活动度时的信度高于单项指标。
研究设计与样本
- 使用COAST-V、COAST-X和RAPID-axSpA三项试验的筛查与基线数据,评估ASAS-OMERACT核心集中强制域候选仪器的重测信度。
- 纳入标准为两次访视间隔最大28天,采用组内相关系数(ICC)评估重测信度,Bland-Altman图提供平均差异和95%一致性界限以计算最小可检测变化(SDC)。
- 数据分别对放射学和非放射学中轴型脊柱关节炎进行分析。
主要发现
- 强直性脊柱炎疾病活动度评分(ASDAS)信度良好(ICC 0.79,SDC 0.6)。
- C反应蛋白信度良好(ICC 0.72-0.79,SDC 12.3-17.0)。
- 巴氏强直性脊柱炎功能指数(BASFI)信度良好(ICC 0.87,SDC 1.1)。
- 36项简短健康调查(SF-36)信度良好(躯体健康总评ICC 0.81,SDC 4.7;心理健康总评ICC 0.80,SDC 7.3)。
- 巴氏强直性脊柱炎疾病活动指数(BASDAI)信度中等(ICC 0.72,SDC 1.1),患者总体评估信度中等(ICC 0.58,SDC 1.5),总背痛信度中等(ICC 0.64,SDC 1.3),夜间背痛信度中等(ICC 0.67,SDC 1.3),晨僵信度中等(ICC 0.52-0.63,SDC 1.5-2.2),疲劳信度中等(ICC 0.65,SDC 1.3),ASAS健康指数信度中等(ICC 0.74,SDC 2.5)。
关键数值与推荐
- ASDAS:ICC 0.79,SDC 0.6。
- C反应蛋白:ICC 0.72-0.79,SDC 12.3-17.0。
- BASFI:ICC 0.87,SDC 1.1。
- SF-36躯体健康总评:ICC 0.81,SDC 4.7;心理健康总评:ICC 0.80,SDC 7.3。
- BASDAI:ICC 0.72,SDC 1.1;患者总体评估:ICC 0.58,SDC 1.5;总背痛:ICC 0.64,SDC 1.3;夜间背痛:ICC 0.67,SDC 1.3;晨僵:ICC 0.52-0.63,SDC 1.5-2.2;疲劳:ICC 0.65,SDC 1.3;ASAS健康指数:ICC 0.74,SDC 2.5。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Aim of this study was to assess test-retest reliability of candidate instruments for the mandatory domains of the Assessment of Spondyloarthritis international Society (ASAS)-Outcome Measures in Rheumatology core set for axial spondyloarthritis (axSpA). METHODS: Screening and baseline data from COAST-V, COAST-X and RAPID-axSpA was used to evaluate test-retest reliability of each candidate instrument for the mandatory domains (disease activity, pain, morning stiffness, fatigue, physical function, overall functioning and health). A maximum time interval of 28 days between both visits was used for inclusion in this study. Test-retest reliability was assessed by intraclass correlation coefficient (ICC). Bland and Altman plots provided mean difference and 95% limits of agreement, which were used to calculate the smallest detectable change (SDC). Data were analysed for radiographic and non-radiographic axSpA separately. RESULTS: Good reliability was found for Ankylosing Spondylitis Disease Activity Score (ICC 0.79, SDC 0.6), C reactive protein (ICC 0.72-0.79, SDC 12.3-17.0), Bath Ankylosing Spondylitis Functional Index (ICC 0.87, SDC 1.1) and 36-item Short-Form Health Survey (ICC Physical Component Summary 0.81, SDC 4.7, Mental Component Summary 0.80, SDC 7.3). Moderate reliability was found for Bath Ankylosing Spondylitis Disease Activity Index (ICC 0.72, SDC 1.1), patient global assessment (ICC 0.58, SDC 1.5), total back pain (ICC 0.64, SDC 1.3), back pain at night (ICC 0.67, SDC 1.3), morning stiffness (ICC 0.52-0.63, SDC 1.5-2.2), fatigue (ICC 0.65, SDC 1.3) and ASAS-Health Index (ICC 0.74, SDC 2.5). Reliability and SDC for the radiographic and non-radiographic axSpA subgroups were similar. CONCLUSION: Overall reliability was good, and comparable levels of reliability were found for patients with radiographic and non-radiographic axSpA, even though most instruments were developed for radiographic axSpA. Composite measures showed higher reliability than single-item measures in assessing disease activity in patients with axSpA.
引用
- Boel A, Navarro-Compán V, van der Heijde D, et al. Test-retest reliability of outcome measures: data from three trials in radiographic and non-radiographic axial spondyloarthritis. RMD Open. 2021. PMID: 34893536. doi:10.1136/rmdopen-2021-001839
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。